Recital 3, Decision_act (EU) 2018/1477

In forcesince 2 Oct 2018

The United Kingdom considers that the assessment of the applications has not been correctly carried out by the reference Member State, since there is a discrepancy between the application rate used in the efficacy studies and the application rate used in the exposure assessment, which is lower (‘the discrepancy’).